Ho sabíeu? Podeu fer doble clic en una paraula per a buscar-la a TermGallery.
Significats de biologic drugs en anglès
Encara no tenim significats per a "biologic drugs".
Ús de biologic drugs en anglès
1
Sius TFF cassettes are used to concentrate clinical and commercial-stage biologicdrugs.
2
It also revamped its research to launch new, harder-to-copy and pricier biologicdrugs.
3
But von Eschenbach said more complex biologicdrugs would be more difficult to weigh.
4
Three major sticking points remain - autos, dairy trade, and monopoly periods for biologicdrugs.
5
Biosimilars are like-for-like versions of expensive new generation biologicdrugs that have come off patent.
6
CoGenesys' pipeline of biologicdrugs includes treatments for cardiovascular disease, multiple sclerosis, diabetes and autoimmune diseases.
7
After that, the original biologicdrugs would only be covered for those indications under exceptional circumstances.
8
Biosimilars are somewhat cheaper copies of biologicdrugs.
9
But there are major issues still outstanding, including monopoly periods for biologicdrugs and phase-out periods for tariffs.
10
The disease is emerging in immunocompromised patients undergoing bone marrow or solid organ transplantation or treatment with biologicdrugs.
11
The amendment would allow U.S. health regulators for the first time to approve potentially cheaper versions of complex biologicdrugs.
12
Amari said the monopoly period for biologicdrugs, which are made from living cells, was the most difficult issue remaining.
13
The monopoly period for biologicdrugs, which are made from living cells, was the most difficult issue remaining, Mr Amari said.
14
Because of the low toxicity of certain biologicdrugs, continued treatment through tumor growth can be ethically considered in study design.
15
The deal also eliminates a 10-year data exclusivity period for biologicdrugs and other pharmaceuticals provisions that Democrats feared would raise prices.
16
The biotech firm has developed technology that transforms both the speed and cost incurred by pharma firms in bringing biologicdrugs to market.